Skip to main content

Table 2 Linear regression model

From: Impact of using artemisinin-based combination therapy (ACT) in the treatment of uncomplicated malaria from Plasmodium falciparum in a non-endemic zone

 

Coefficient

Typified coefficient

B

Typical error

Beta

Significance

Treatment with quinine/atovaquone–proguanil or ACT

−1.349

0.293

−0.409

<0.001

Hb on admission

0.314

0.097

0.284

<0.01

Platelets on admission

−0.007

0.002

−0.258

<0.01

Average parasitaemia

−0.009

0.319

−0.003

0.98

High parasitaemia

1.083

0.449

0.225

0.02

  1. ACT artemisinin-based combination therapy
  2. R2 = 0.404 (p < 0.001). The model we have constructed explains 40.4 % of the variability in the average hospital stay. The variables that influence the average stay are the type of treatment, Hb, platelets and having elevated parasitaemia. The variable with the greatest power of association is the treatment type, which has a typified coefficient of 0.409. For the same level of Hb, platelets or parasitaemia, the use of ACT results in almost 1 day less of hospitalization (−1.35 days)